Mylan clears extra $164M in profit from EpiPen that CEO didn't disclose to Congress

Doug G. Ware
CANONSBURG, Pa., Sept. 26 (UPI) — Drug maker Mylan admitted its top executive was only partly truthful last week when telling Congress how much profit it takes from each EpiPen sold. …read more

Source:: National and World Stories

      

You must be logged in to post a comment Login